Design and characterization of swietenia mahagoni jacq. Mediated silver nanoparticles for hyperglycemic and hyperlipidemic control

L V Vigneshwaran

Authors

L V Vigneshwaran Department of Pharmaceutics, Malik Deenar college of Pharmacy, Kasaragod. Author

Abstract

The present study was designed to evaluate the design and characterization of swieteniamahagonijacq. mediated silver nanoparticles for hyperglycemic and hyperlipidemiccontrol. Usingtheextraction methods like soxhlet extraction, benzene extraction, Ethanolic Extraction, Ethyl acetate extraction, petroleum ether extraction.Animals were randomly divided into 5 groups. Group 1- normal control, Group 2- diabetic control, Group3 –treatment control Swieteniamahagoni 100mg/kg, Group 4 – Swieteniamahagoni 200mg/kg treated group, Group 5 – Glibenclamide 5mg/kg.The levels of biochemical parameter, body weight, serum lipid profile, serum total cholesterol, serum glycerides, VLDL AND & HDL cholesterol, HDL cholesterol, Hemoglobin &glycated

hemoglobin were examined in each of these groups. Chronic administration of swieteniamahagoni at a dose of 100mg/kg & 200mg/kg, p.o. for a period of 21 days markedly decreased the level of blood glucose level & lipid level. Phamacological studies were assessed forbioassessment, clinical trials, and toxicological studies. Quantitative estimation of total phenolic and flavonoid likeestimation of total phenolic content, total flavonoid content,HPTLC investigation of ethanol extract.Taken together, the results suggested that treatment reduced hyperglycemic and hyperlipidemic control. This study demonstrates the swieteniamahagonijacq. Mediated silver nanoparticles for hyperglycemic and hyperlipidemic control.

Downloads

Download data is not yet available.

References

Surender, V. (2016). Nanoparticles: A comprehensive review. Journal of Chemical and Pharmaceutical Research, 8(8), 102–114.

Sironmani, A. (2011). Silver nanoparticles—Universal multifunctional nanoparticles for biosensing, imaging for diagnostics and targeted drug delivery for therapeutic applications. In Drug Discovery and Development - Present and Future (pp. 463–488).

Bhat, M., Kothiwale, S. K., Tirmale, A. R., Bhargava, S. Y., & Joshi, B. N. (2011). Antidiabetic properties of Azadirachta indica and Bougainvillea spectabilis: In vivo studies in murine diabetes model. Evidence-Based Complementary and Alternative Medicine, 2011, 1–9.

Lemmens, R. H. M. J. (2009). Swietenia mahagoni (L.) Jacq. In D. Louppe, A. A. Oteng-Amoako, & H. M. J. Lemmens (Eds.), Timbers/Bois d’œuvre 1 [CD-ROM] (Prota 7(1)). Wageningen, Netherlands: Prota / Vallabh Prakashan.

Islam, N. (2009). Nanotechnology innovation system: Understanding hidden dynamics of nanoscience fusion trajectories. Technological Forecasting and Social Change, 76(1), 128–140.

Jain, K. K. (2008). Drug delivery systems (Methods in Molecular Biology). Switzerland: Humana Press, 1–3.

De Jong, W. H., & Borm, P. J. (2008). Drug delivery and nanoparticles: Applications and hazards. International Journal of Nanomedicine, 3(2), 133–149.

Council of Scientific and Industrial Research. (2005). The wealth of India: Raw materials (Reprint ed.). New Delhi: Publications and Information Directorate. (Original work published 1976)

Bader, A. R. (n.d.). The development of targeted drug delivery system for rheumatoid arthritis treatment. Syracuse Biomaterials Institute, 111–132.

Bopana, K. N., Kannan, J., Gadgil, S., Balaram, R., & Rathod, S. P. (1997). Antidiabetic and antihyperlipidaemic effects of neem seed kernel powder on alloxan diabetic rabbits. Indian Journal of Pharmacology, 29, 162–167.